Related Experiment Video
Updated: Jan 5, 2026
Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
Nitric oxide and the CABG patient
Tatsiana Suvorava1, Vu Thao-Vi Dao, Murat Bas
1Institute of Pharmacology and Clinical Pharmacology, Heinrich Heine University, Duesseldorf, Germany.
Insights
Coronary artery bypass grafting (CABG) success is challenged by graft issues. Endothelial nitric oxide (NO) bioavailability is crucial for graft function and patency, warranting further investigation in CABG patients.
Area of Science:
- Cardiovascular Surgery
- Vascular Biology
- Endothelial Function
Background:
- Coronary artery bypass grafting (CABG) success is limited by post-operative complications like thrombosis, de-endothelialization, intimal hyperplasia, and atherosclerosis.
- The endothelium's role in graft patency is critical, with nitric oxide (NO) bioavailability being a key factor.
Purpose of the Study:
- To investigate the role of endothelial nitric oxide (NO) bioavailability in the function and patency of grafts after coronary artery bypass grafting (CABG).
- To explore the vasoprotective potential of NO in CABG patients.
Main Methods:
- Review of existing literature on CABG complications and endothelial function.
- Analysis of factors influencing NO bioavailability, including graft type, surgical procedure, and patient management.
- Assessment of current data supporting the role of NO in graft patency.
Main Results:
- Graft type, harvesting, storage, surgical approach, physical activity, and drug therapy can influence NO bioavailability.
- While the exact impact of endothelial NO bioavailability on graft patency and clinical outcomes remains under investigation, current evidence suggests a positive role.
Conclusions:
- Endothelial NO bioavailability is a significant factor for graft function and patency in CABG patients.
- Further research is needed to fully elucidate the vasoprotective effects of NO and optimize its therapeutic potential in CABG patients.
Abstract:
The post surgery success of coronary artery bypass grafting (CABG) is counteracted by thrombosis and de-endothelialization, intimal hyperplasia and, over the long term, atherosclerosis. There are many reasons to assume that in CABG patients vascular bioavailability of NO generated by the endothelium plays an important role for graft function. This holds true for factors such as graft type, harvesting and storage, the type of surgery, non-pharmacologic prevention of risk factors, for example, regular physical activity (if feasible), and drug therapy. Although the precise role of graft endothelial NO bioavailability for graft patency and clinical endpoints is still uncertain, current data rather speak in favor of NO indicating that the potential of vasoprotective activities of NO in the CABG patient deserves further investigation.
More Related Videos
08:35Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
08:23Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
Published on: February 16, 2022
Related Concept Videos
01:20Angina V: Nursing Management
01:26Angina IV: Management
01:27Coronary Artery Disease V: Interprofessional Care
01:28Nitric Oxide Signaling Pathway
01:16Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
01:23Antihypertensive Drugs: Vasodilators